Teprotumumab Phase III Trial Top Line Results Released

March 1, 2019

Horizon Pharma has just released top line results for the Phase III trial of Teprotumumab, a potential new treatment for thyroid eye disease. Detailed Phase III data will be submitted for publication in a peer-reviewed journal and presented at a medical congress later this year. Click this link to learn more: http://bit.ly/2ECfINj

Raymond Douglas, M.D., Ph.D., the study’s co-principal investigator, director of the orbital and thyroid eye disease program ...

Read More

GDATF Statement on the Passing of President George H.W. Bush

Dec. 3, 2018

​Statement from the Graves' Disease and Thyroid Foundation (GDATF) on the passing of President George H.W. Bush:

We were saddened to learn of the passing of Pres. George H.W. Bush, and extend our condolences to his family and friends.

With his diagnosis of Graves' disease in 1991, Pres. Bush not only raised the profile of Graves' disease in the public consciousness, but was also an example of how patients can persevere and lead ...

Read More

Wendy Williams Video Greeting!

July 24, 2018

Talk show host Wendy Williams from The Wendy Williams Show recorded a special greeting to kick off the Graves' Disease & Thyroid Foundation's 2018 Patient & Family Conference in San Diego, CA!

On behalf of the GDATF's staff and Board - and all of our conference attendees - a million thanks to Wendy and her team for taking the time to let Graves' patients know that they are not alone!

Click here to watch the video!

Read More

Recent News

• Top Line Teprotumumab Phase III Trial Results Released

  March 1, 2019, 8:22 a.m.

• Registration Open for Los Angeles Patient Event!

  Feb. 22, 2019, 11:08 a.m.

• Los Angeles Patient Education Event!

  Feb. 6, 2019, 10:01 a.m.

• Holiday Schedule 2018-19

  Dec. 23, 2018, 8:56 a.m.

• GDATF 2018 Annual Appeal Letter

  Dec. 20, 2018, 10:21 a.m.